Chairpersons:
J.P. Bassand (France) – H. Dargie (UK)
|
| Introduction:
H. Dargie (UK) |
Specificity of inhibiting the renin angiotensin aldosterone system with perindopril
R. Ferrari (Italy) |
Prevention of events in coronary artery disease patients with ACE inhibitors: new insights from EUROPA
K. Fox (UK) |
Rationale and design of the PREAMI study: a randomised trial in patients with myocardial infarction and preserved ejection fraction
L. Tavazzi (Italy) |
Effects of perindopril on remodeling in elderly patients with acute myocardial infarction: the PREAMI results
W.J. Remme (Netherlands) |
From acute myocardial infarction to secondary prevention: evidence for benefits of perindopril in coronary artery disease patients
M. Bertrand (France) |
| Conclusion:
J. P. Bassand (France) |